• Explore /
  • Poster
  • / A multicenter phase I study of intravenous administration of reolysin in combination with irinotecan/fluorouracil/leucovorin (FOLFIRI) in patients (pts) with oxaliplatin-refractory/intolerant <i>KRAS-</i>mutant metastatic colorectal cancer (mCRC).

A multicenter phase I study of intravenous administration of reolysin in combination with irinotecan/fluorouracil/leucovorin (FOLFIRI) in patients (pts) with oxaliplatin-refractory/intolerant KRAS-mutant metastatic colorectal cancer (mCRC).

Abstract Poster

Authors

null

Allyson Ocean

Weill Cornell Medical College, New York Presbyteri

Allyson Ocean , Tanios Bekaii-Saab , Imran Chaudhary , Romae Palmer , Paul Christos , Alice Mercado , Erika Florendo , Veronica Rosales , Joseph Ruggiero , Elizabeta Popa , Melissa Wilson , Mohammad Ghalib , Yijuan Hou , Umang Shah , Lakshmi Rajdev , Tarek Elrafei , George Gill , Matthew Coffey , Manish Shah , Sanjay Goel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01274624

Citation

J Clin Oncol 31, 2013 (suppl 4; abstr450)

DOI

10.1200/jco.2013.31.4_suppl.450

Abstract #

450

Poster Bd #

C6

Abstract Disclosures

Similar Posters

First Author: Shigenori Kadowaki

First Author: Patrick M Boland

First Author: Anne Thomas

First Author: A. L. Thomas